Stockrabit · Analysts
Questions across 1 call

Rahul Choudhary

Firm not listed in source transcripts

Natco Pharma Limited

Natco Pharma Limited CC-Jun24.pdf · 2024-08-13
Hello, sir. My question is regarding the API revenue and domestic formulation. API revenue seems stagnant for many years now. And in domesti c formulation, if I am not wrong, you had said last con call about some jackpot ideas. So is this amalgamated in the a jackpot idea or is it something else?
Right, sir. Sir, my other question was on the 28 products on the Para 4, pipeline. When we say 13 are approved, tentative or fully, it means -- what does it mean, that litigation is ongoing or we've got the final clearance to launch in a particular future?